This compound is a deuterated form of angiotensin II, featuring a pentadeutero modification on the phenylalanine residue. It is designed for use as a reference standard in analytical research and quantitative mass spectrometry studies, leveraging the stable isotope label for internal standardization.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1926163-73-6
Angiotensin I human acetate salt hydrate
research compound
Angiotensin I
pharmaceutical raw material
Angiotensin acetate
research peptide hormone
1-9-Luteinizing hormone-releasing factor (swine), 4-(O-acetyl-L-serine)-6-(O-(1,1-dimethylethyl)-D-serine)-, mixt. with 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-(phenylmethyl)-L-histidyl-L-leucine
research compound
Homoserine
research compound
(2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-(tert-butoxycarbonyl)amino-1,6-diphenylhexane
research compound
4-Chloro-1-[4-chloro-2-(trimethylstannyl)phenyl]-1H-1,2,3-triazole
research compound
Angiotensin II
pharmaceutical raw material
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-(2,3,4,5,6-pentadeuteriophenyl)ethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
CZGUSIXMZVURDU-LFAVMEPXSA-N
[2H]C1=C(C(=C(C(=C1[2H])[2H])C[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N)[2H])[2H]
—